Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cebranopadol for Opioid Withdrawal in Chronic Pain Patients
NCT07874620Phase 2Recruiting
- Start
- Oct 2026
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
A Phase 2 trial of cebranopadol in opioid withdrawal. Started Oct 2026; status: recruiting.
02
Drugs
cebranopadol
03
Conditions
opioid withdrawal
Beyond the preview
Go deeper on NCT07874620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07874620.